Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02345772
Title Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (Taxotere, Trastuzumab and Pertuzumab) in Patients With HER2-positive and ER-Positive Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Western Regional Medical Center

Her2-receptor positive breast cancer



Docetaxel + Pertuzumab + Trastuzumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Western Regional Medical Center, Inc. Goodyear Arizona 85338 United States Details
*Shaded cells indicate that there was no data available from for the field